Novartis AG
Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections
Last updated:
Abstract:
The invention provides compounds of Formula (I): ##STR00001## as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.
Status:
Application
Type:
Utility
Filling date:
13 Jul 2021
Issue date:
10 Feb 2022